USRM's free cash flow for Q was $-43.06K. For the fiscal year, USRM's free cash flow was decreased by $753.09K and operating cash flow was $-43.06K. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Operating Cash Flow	$ -304.85K	$ -304.85K	$ -1.06M	$ -478.89K	$ -1.21M	$ 602.47K
Investing Cash Flow	-	-	-	$ 0.00	$ 166.83K	$ 311.70K
Financing Cash Flow	$ 270.59K	$ 270.59K	$ 1.08M	$ 497.46K	$ -312.99K	$ -543.82K
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 60.09K	$ 5.13K	$ 39.39K	$ 18.57K	$ 0.00	$ 1.36M
Income Tax Paid Supplemental Data	-	-	-	$ 0.00	$ 0.00	$ 0.00
Interest Paid Supplemental Data	$ 6.11K	$ 6.11K	$ 22.76K	$ 40.99K	$ 782.65K	$ 1.11M
Issuance Of Capital Stock	$ 85.00K	$ 85.00K	$ 275.00K	$ 0.00	$ 50.00K	$ 367.70K
Issuance Of Debt	$ 79.54K	$ 185.59K	$ 803.76K	$ 195.00K	$ 194.26K	$ 220.21K
Repayment Of Debt	$ 27.92K	$ 158.59K	$ 37.76K	$ -45.71K	$ -834.09K	$ -1.36M
Free Cash Flow	$ -304.85K	$ -304.85K	$ -1.06M	$ -478.89K	$ -1.21M	$ 602.47K
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

US Stem Cell Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing